China SXT Pharmaceuticals, Inc. (SXTC)

USD 2.49

(-0.8%)

Total Assets Summary of China SXT Pharmaceuticals, Inc.

  • China SXT Pharmaceuticals, Inc.'s latest annual total assets in 2024 was 23.12 Million USD , down -21.75% from previous year.
  • China SXT Pharmaceuticals, Inc.'s latest quarterly total assets in 2024 FY was 23.12 Million USD , down -21.75% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported annual total assets of 29.55 Million USD in 2023, down -11.9% from previous year.
  • China SXT Pharmaceuticals, Inc. reported annual total assets of 33.54 Million USD in 2022, down -2.9% from previous year.
  • China SXT Pharmaceuticals, Inc. reported quarterly total assets of 14.58 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • China SXT Pharmaceuticals, Inc. reported quarterly total assets of 23.12 Million USD for 2024 FY, down -21.75% from previous quarter.

Annual Total Assets Chart of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Historical Annual Total Assets of China SXT Pharmaceuticals, Inc. (2024 - 2016)

Year Total Assets Total Assets Growth
2024 23.12 Million USD -21.75%
2023 29.55 Million USD -11.9%
2022 33.54 Million USD -2.9%
2021 34.54 Million USD 59.19%
2020 21.7 Million USD 24.22%
2019 17.47 Million USD 128.14%
2018 7.65 Million USD 40.99%
2017 5.43 Million USD -13.75%
2016 6.29 Million USD 0.0%

Peer Total Assets Comparison of China SXT Pharmaceuticals, Inc.

Name Total Assets Total Assets Difference
Journey Medical Corporation 76.84 Million USD 69.906%
ANI Pharmaceuticals, Inc. 904.42 Million USD 97.443%
Aquestive Therapeutics, Inc. 57.41 Million USD 59.722%
Pacira BioSciences, Inc. 1.57 Billion USD 98.531%
Sunshine Biopharma, Inc. 27.34 Million USD 15.431%
Sunshine Biopharma, Inc. 27.34 Million USD 15.431%
SCYNEXIS, Inc. 128.41 Million USD 81.99%
Safety Shot Inc 12.7 Million USD -81.971%
Alpha Teknova, Inc. 128.58 Million USD 82.014%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 97.977%
Bright Green Corporation 17.4 Million USD -32.891%
Dynavax Technologies Corporation 997.09 Million USD 97.681%
Esperion Therapeutics, Inc. 205.79 Million USD 88.762%
Cosmos Health Inc. 66.29 Million USD 65.115%
PainReform Ltd. 9.93 Million USD -132.901%
Embecta Corp. 1.21 Billion USD 98.096%
Intra-Cellular Therapies, Inc. 728.29 Million USD 96.824%
Procaps Group, S.A. 460.18 Million USD 94.974%
Theratechnologies Inc. 77.76 Million USD 70.262%
Harrow Health, Inc. 311.75 Million USD 92.582%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -55.288%
Biofrontera Inc. 27.93 Million USD 17.202%
DURECT Corporation 45.18 Million USD 48.821%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 98.359%
Cronos Group Inc. 1.13 Billion USD 97.961%
OptiNose, Inc. 107.72 Million USD 78.532%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 95.091%
Kala Pharmaceuticals, Inc. 55.94 Million USD 58.664%
RedHill Biopharma Ltd. 23.04 Million USD -0.347%
Organogenesis Holdings Inc. 460.02 Million USD 94.973%
Guardion Health Sciences, Inc. 11.91 Million USD -94.049%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 71.719%
Radius Health, Inc. 1.71 Billion USD 98.652%
Universe Pharmaceuticals INC 53.28 Million USD 56.599%
ProPhase Labs, Inc. 91.92 Million USD 74.842%
Phibro Animal Health Corporation 982.18 Million USD 97.645%
Procaps Group S.A. 460.18 Million USD 94.974%
Alvotech 950.09 Million USD 97.566%
TherapeuticsMD, Inc. 43.3 Million USD 46.6%
Viatris Inc. 47.68 Billion USD 99.952%
Rockwell Medical, Inc. 52.17 Million USD 55.672%
Aytu BioPharma, Inc. 118.09 Million USD 80.417%
SIGA Technologies, Inc. 254.83 Million USD 90.925%
Tilray Brands, Inc. 4.33 Billion USD 99.467%
Lifecore Biomedical, Inc. 273.7 Million USD 91.55%
Shineco, Inc. 84.17 Million USD 72.526%
PetIQ, Inc. 868.22 Million USD 97.336%
Regencell Bioscience Holdings Limited 8.43 Million USD -174.075%
Incannex Healthcare Limited 17.04 Million USD -35.666%
Neurocrine Biosciences, Inc. 3.25 Billion USD 99.289%
Alimera Sciences, Inc. 153.52 Million USD 84.936%
Silver Spike Investment Corp. 88.57 Million USD 73.89%
Assertio Holdings, Inc. 286.41 Million USD 91.925%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -288.577%
Petros Pharmaceuticals, Inc. 33.79 Million USD 31.568%
Clever Leaves Holdings Inc. 31.24 Million USD 25.977%
Cyclo Therapeutics, Inc. 13.24 Million USD -74.576%
Avadel Pharmaceuticals plc 261.12 Million USD 91.143%
Hempacco Co., Inc. 18.04 Million USD -28.177%
Talphera, Inc. 20.39 Million USD -13.396%
Alvotech 950.09 Million USD 97.566%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 94.306%
Lantheus Holdings, Inc. 1.65 Billion USD 98.599%
Currenc Group, Inc. 141.49 Million USD 83.655%
Kamada Ltd. 351.96 Million USD 93.429%
Indivior PLC 1.95 Billion USD 98.815%
Evoke Pharma, Inc. 7.06 Million USD -227.183%
Flora Growth Corp. 23.62 Million USD 2.112%
Cyclo Therapeutics, Inc. 13.24 Million USD -74.576%
Evolus, Inc. 188.99 Million USD 87.763%
HUTCHMED (China) Limited 1.27 Billion USD 98.193%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 98.471%
Akanda Corp. 8.83 Million USD -161.618%